[Immunisation schedule of the Spanish Association of Paediatrics: 2015 recommendations]
Insights
The Spanish Association of Paediatrics updates its optimal childhood immunization schedule annually, incorporating safety and effectiveness data for vaccines like hepatitis B, MMR, and DTaP.
Area of Science:
- Pediatrics
- Vaccinology
- Public Health
Background:
- The Advisory Committee on Vaccines (ACV) annually updates the recommended immunization schedule for children in Spain.
- The schedule considers epidemiological data, vaccine safety, effectiveness, and efficiency.
- The ACV aims to provide the optimal vaccination calendar for all children residing in Spain.
Purpose of the Study:
- To present the updated annual immunization schedule recommended by the ACV for children in Spain.
- To highlight key vaccine recommendations, including timing, dosage, and specific populations.
- To advocate for the inclusion and accessibility of certain vaccines in the national schedule.
Main Methods:
- Review of epidemiological data.
- Evaluation of evidence on vaccine safety, effectiveness, and efficiency.
- Expert consensus and recommendation development by the ACV.
Main Results:
- Specific recommendations for hepatitis B (birth or 2 months), MMR and varicella (12 months, booster at 2-3 years), and DTaP/Tdap (6 years, booster at 11-12 years).
- Emphasis on Tdap for pregnant women and newborns' contacts, and HPV vaccination for girls (11-12 years, 2-dose scheme).
- Reiteration of pneumococcal vaccination recommendation, advocating for meningococcal B vaccine availability, and proposing free varicella vaccines.
Conclusions:
- The updated schedule represents the optimal vaccination strategy for children in Spain.
- Key vaccines like pneumococcal and meningococcal B should be integrated into routine immunization.
- Increased accessibility and availability of vaccines such as varicella are crucial for public health.
Abstract:
The Advisory Committee on Vaccines of the Spanish Association of Paediatrics updates the immunisation schedule every year, taking into account epidemiological data as well as evidence on the safety, effectiveness and efficiency of current vaccines, including levels of recommendation. In our opinion, this is the optimal vaccination calendar for all children resident in Spain. Regarding the vaccines included in the official unified immunization schedule, the Committee emphasizes the administration of the first dose of hepatitis B either at birth or at 2 months of life; the recommendation of the first dose of MMR and varicella vaccine at the age of 12 months, with the second dose at the age of 2-3 years; DTaP or Tdap vaccine at the age of 6 years, followed by another Tdap booster dose at 11-12 years old; Tdap strategies for pregnant women and household contacts of the newborn, and immunization against human papillomavirus in girls aged 11-12 years old with a 2 dose scheme (0, 6 months). The Committee reasserts its recommendation to include vaccination against pneumococcal disease in the routine immunisation schedule, the same as it is being conducted in Western European countries. The recently authorised meningococcal B vaccine, currently blocked in Spain, exhibits the profile of a universal vaccine. The Committe insists on the need of having the vaccine available in communitary pharmacies. It has also proposed the free availability of varicella vaccines. Their efectiveness and safety have been confirmed when they are administred from the second year of life. Vaccination against rotavirus is recommended in all infants. The Committee stresses the need to vaccinate population groups considered at risk against influenza and hepatitis A.
More Related Videos
07:33Conversion of Human Induced Pluripotent Stem Cells iPSCs into Functional Spinal and Cranial Motor Neurons Using PiggyBac Vectors
Published on: May 1, 2019
09:17A DNA/Ki67-Based Flow Cytometry Assay for Cell Cycle Analysis of Antigen-Specific CD8 T Cells in Vaccinated Mice
Published on: January 5, 2021
Related Concept Videos
Vaccinations
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Drug Dosing: Infants and Children
Pharmacokinetics in Pediatric Patients: Drug Excretion
Vaccines
Respiratory Syncytial Virus Disease
